InicioCarterasWatchlistComunidadDescubreScreener
NOT FOR DISTRIBUTION

Ackermans & Van Haaren NV

Informe acción ENXTBR:ACKB

Capitalización de mercado: €8.8b

  • Resumen empresa
  • Valoración
  • Crecimiento Futuro
  • Rendimiento pasado
  • Salud Financiera
  • Dividendos
  • Dirección
  • Propiedad
  • Información adicional
  • Comunidad de acciones

Ackermans & Van Haaren Crecimiento futuro

Future controles de criterios 0/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Ackermans & Van Haaren de 0.8% y 1.3% por año respectivamente. Se prevé que el BPA crezca en un 2% al año. Se espera que la rentabilidad financiera sea de 8.5% en 3 años.

Información clave

0.8%

Tasa de crecimiento de los beneficios

1.98%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Construction11.8%
Tasa de crecimiento de los ingresos1.3%
Rentabilidad financiera futura8.54%
Cobertura de analistas

Low

Última actualización04 Sep 2026

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

User avatar
Actualización de narrativa • Sep 04

ACKB: Future Returns Will Reflect Higher Multiple And Renewables-Focused Portfolio Shift

Analysts have increased their price target for Ackermans & Van Haaren to €311.86 from €304.14, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples. What’s in the News for Ackermans & Van Haaren Ackermans & Van Haaren reported net profit of €339.6 million for the first half of 2026, according to recent company updates.
User avatar
Actualización de narrativa • Jun 25

ACKB: Future Returns Will Reflect Higher Multiple And Adjusted Profitability Assumptions

Analysts have raised their Ackermans & Van Haaren price target slightly to about €304 from roughly €296. This reflects updated assumptions on the discount rate, profit margin and future P/E that together indicate a modestly higher fair value estimate.
User avatar
Actualización de narrativa • Jun 05

ACKB: Future Returns Will Reflect Raised Price Outlook And Updated Risk Profile

Analysts have lifted their price target for Ackermans & Van Haaren to €330 from €289, reflecting updated views on the stock's earnings profile and valuation assumptions. What's in the News The analyst price target for Ackermans & Van Haaren has been raised to €330 from €289, reflecting updated earnings assumptions and a revised valuation framework.
User avatar
Actualización de narrativa • May 17

ACKB: Future Returns Will Reflect Updated Risk Profile And P E Assumptions

Analysts have raised their price target on Ackermans & Van Haaren to €330 from €289, citing updated views on the stock's risk profile, earnings outlook and P/E assumptions. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a €330 price target as better aligning the stock with their updated P/E assumptions, suggesting the current valuation may not fully reflect their earnings expectations.
User avatar
Actualización de narrativa • Apr 23

ACKB: Future Returns Will Rely On P/E Support And Risk Assumptions

Analysts have lifted their price target on Ackermans & Van Haaren to €330 from €289, reflecting updated views on risk, growth and expected P/E that keep the stock aligned with their broader investment case. Analyst Commentary Bullish Takeaways Bullish analysts see the higher €330 price target as better aligned with their current assumptions on risk, growth and P/E, which they view as still coherent with the existing investment case.
User avatar
Actualización de narrativa • Apr 08

ACKB: Future Returns Will Rely On P/E Support And Margin Resilience

Ackermans & Van Haaren's analyst price target has been revised to €330 from €289. Analysts point to updated assumptions on fair value, discount rate and future P/E as key drivers of the adjustment.
User avatar
Actualización de narrativa • Mar 25

ACKB: Future Upside Will Depend On Sustained Margins And Earnings Power

Analysts have raised their price target on Ackermans & Van Haaren to €330 from €289, reflecting updated views on the stock's valuation drivers and risk profile. Analyst Commentary Bullish analysts are signaling a more constructive stance on Ackermans & Van Haaren, which is reflected in the higher price target of €330 compared with the previous €289 level.
User avatar
Actualización de narrativa • Mar 09

ACKB: Fair Outlook Will Rely On Margins And Revenue Assumptions

The average analyst price target for Ackermans & Van Haaren has been adjusted from €277.71 to €291.86, with analysts citing updated assumptions around revenue growth, profit margins and forward P/E as key factors behind the change. Valuation Changes Fair Value: updated from €277.71 to €291.86, a modest upward adjustment in the modelled estimate.
User avatar
Actualización de narrativa • Feb 23

ACKB: Fair Outlook Will Depend On Margins And Assumed Revenue Expansion

Analysts have lifted their price target on Ackermans & Van Haaren from €263.43 to €277.71, citing updated assumptions on revenue growth, profit margins and future P/E that point to a slightly higher fair value under a similar discount rate. Valuation Changes Fair Value: updated from €263.43 to €277.71, representing a modest uplift in the modelled estimate.
User avatar
Actualización de narrativa • Feb 08

ACKB: Fair Outlook Will Rely On Stable Margins And Slight Multiple Adjustment

Analysts have kept their fair value estimate for Ackermans & Van Haaren steady at €263.43, with only marginal tweaks to assumptions such as the discount rate and future P/E. This reflects a broadly unchanged view of the company’s risk and earnings profile.
Artículo de análisis • Jan 28

There's Been No Shortage Of Growth Recently For Ackermans & Van Haaren's (EBR:ACKB) Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
User avatar
Actualización de narrativa • Jan 24

ACKB: Steady Outlook Will Rely On Stable Margins And Modest Multiple Shift

Ackermans & Van Haaren's analyst price target has been nudged higher, with fair value estimates moving from €254.83 to €263.43 as analysts factor in a slightly higher assumed future P/E and modest tweaks to the discount rate, long term margin, and growth inputs. Valuation Changes Fair Value: updated from €254.83 to €263.43, reflecting a modest uplift in the modelled estimate.
User avatar
Actualización de narrativa • Jan 09

ACKB: Steady Fair Value And Minor Assumption Tweaks Will Shape Outlook

Analysts have kept their fair value estimate for Ackermans & Van Haaren steady at €254.83, indicating only minor adjustments in discount rate, revenue growth, profit margin and future P/E assumptions rather than a change in overall conviction. Valuation Changes Fair Value Estimate: Held steady at €254.83 per share, with no change between the previous and updated assessment.
Artículo de análisis • Jan 07

Ackermans & Van Haaren NV (EBR:ACKB) Shares Could Be 33% Below Their Intrinsic Value Estimate

Key Insights Using the 2 Stage Free Cash Flow to Equity, Ackermans & Van Haaren fair value estimate is €353 Ackermans...
User avatar
Actualización de narrativa • Dec 14

ACKB: Modest Discount Rate Shift Will Support Future Earnings Strength

Analysts have modestly raised their price target on Ackermans & Van Haaren to €254.83, reflecting slightly lower discount rate assumptions while keeping long term growth and profitability expectations broadly unchanged. Valuation Changes Fair Value: Unchanged at approximately €254.83 per share, indicating no revision to the central valuation outcome.
Artículo de análisis • Dec 05

Ackermans & Van Haaren NV's (EBR:ACKB) Business Is Trailing The Market But Its Shares Aren't

There wouldn't be many who think Ackermans & Van Haaren NV's ( EBR:ACKB ) price-to-earnings (or "P/E") ratio of 13.9x...
User avatar
Actualización de narrativa • Nov 29

ACKB: Future Earnings Strength Will Support Fair Value Estimate

Analysts have modestly adjusted their price target for Ackermans & Van Haaren, maintaining a fair value estimate of €254.83 as incremental shifts in discount rate and forward earnings expectations balance with softer revenue growth projections. Valuation Changes Fair Value Estimate remains unchanged at €254.83 per share.
User avatar
Actualización de narrativa • Nov 15

ACKB: Net Profit Set To Climb At Least 15% In 2025

Analysts have raised their price target for Ackermans & Van Haaren from €253 to approximately €254.83. This change is attributed to a marginal increase in fair value, updated profit margin forecasts, and a slightly higher expected future price-to-earnings ratio.
User avatar
Actualización de narrativa • Nov 01

ACKB: Net Profit Set To Increase At Least 15% In 2025 Guidance

Analysts have reaffirmed their price target for Ackermans & Van Haaren at €253, citing minimal adjustments in their key financial assumptions and market outlook. What's in the News Ackermans & Van Haaren has issued earnings guidance for 2025 and projects a net profit increase of at least 15% (Company Guidance).
User avatar
Actualización de narrativa • Oct 18

Delen Private Bank And DEME Will Forge Future Investment Opportunities

Analysts have reiterated their price target for Ackermans & Van Haaren at €253.00. They cite largely unchanged revenue growth and profit margin forecasts as supporting factors for maintaining their fair value estimate.
Artículo de análisis • Oct 16

Ackermans & Van Haaren (EBR:ACKB) Is Doing The Right Things To Multiply Its Share Price

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
User avatar
Actualización de narrativa • Oct 04

Delen Private Bank And DEME Will Forge Future Investment Opportunities

Analysts have raised their price target for Ackermans & Van Haaren from €244.67 to €253.00. This change reflects improved expectations for revenue growth and future valuation multiples, even though only minor adjustments were made to profitability forecasts.
Artículo de análisis • Sep 26

These 4 Measures Indicate That Ackermans & Van Haaren (EBR:ACKB) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
User avatar
Actualización de narrativa • Aug 30

Delen Private Bank And DEME Will Forge Future Investment Opportunities

The upward revision in Ackermans & Van Haaren’s price target is primarily driven by improved consensus forecasts for both revenue growth and net profit margin, raising the fair value estimate from €234.67 to €244.67. What's in the News Ackermans & Van Haaren expects net profit to increase by at least 15% for 2025.
User avatar
Nueva narrativa • Apr 06

Delen Private Bank And DEME Will Forge Future Investment Opportunities

Strong growth and collaboration in financial services suggest sustained revenue increases and enhanced banking operations.

Previsiones de crecimiento de beneficios e ingresos

ENXTBR:ACKB - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20286,2796929481,2862
12/31/20276,0336609041,2342
12/31/20266,2266507141,0333
6/30/20265,9596597221,283N/A
3/31/20265,9606266291,144N/A
12/31/20255,9625935361,005N/A
9/30/20256,0765637361,112N/A
6/30/20256,1915339371,218N/A
3/31/20256,1174961,0181,314N/A
12/31/20246,0434601,1001,410N/A
9/30/20245,8614448541,199N/A
6/30/20245,679429607988N/A
3/31/20245,450414396803N/A
12/31/20235,222399185619N/A
9/30/20234,959500150621N/A
6/30/20234,697601116622N/A
3/31/20234,549653159669N/A
12/31/20224,401706202717N/A
9/30/20224,446611286747N/A
6/30/20224,491517369777N/A
3/31/20224,394462416779N/A
12/31/20214,297407463782N/A
9/30/20214,181373495779N/A
6/30/20214,064339528776N/A
3/31/20213,987285439682N/A
12/31/20203,910230350587N/A
9/30/20203,889234202501N/A
6/30/20203,86923854414N/A
3/31/20204,070317N/A499N/A
12/31/20194,270395N/A585N/A
9/30/20194,334393N/A612N/A
6/30/20194,398391N/A640N/A
3/31/20194,435340N/A534N/A
12/31/20184,472290N/A428N/A
9/30/20184,402285N/A425N/A
6/30/20184,333281N/A422N/A
3/31/20184,149292N/A485N/A
12/31/20173,965303N/A549N/A
9/30/20173,938288N/A636N/A
6/30/20173,910273N/A723N/A
3/31/20173,785249N/A691N/A
12/31/20163,659224N/A658N/A
9/30/20163,639217N/A566N/A
6/30/20163,620210N/A474N/A
3/31/20163,819248N/A444N/A
12/31/20154,019285N/A414N/A
9/30/20154,041281N/AN/AN/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (0.8% por año) de ACKB está por debajo de la tasa de ahorro (2.6%).

Beneficios vs. Mercado: Se prevé que los beneficios (0.8% al año) de ACKB crezcan menos que el mercado Belgian (11.6% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de ACKB crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (1.3% al año) de ACKB crezcan más despacio que el mercado de Belgian (7.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 1.3% al año) de ACKB crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de ACKB sea baja dentro de 3 años (8.5%).


Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/09/09 10:51
Precio de las acciones al final del día2026/09/09 00:00
Beneficios2026/06/30
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
  • Formulario SEC 10-K
  • Formulario SEC 10-Q
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
  • Informes de análisis
  • Blue Matrix
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
  • Datos de mercado ICE
  • Formulario S-1 de la SEC
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
  • Formulario SEC 4
  • Formulario SEC 13D
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
  • Formulario SEC 10-K
  • Formulario SEC DEF 14A
Principales avances10 años
  • Anuncios de empresas
  • Formulario SEC 8-K

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Ackermans & Van Haaren NV está cubierta por 9 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Grégoire HermannBerenberg
Mourad LahmidiBNP Paribas
Joren Van AkenDegroof Petercam

Toma mejores decisiones de inversión en cualquier lugar

Escanea para descargar
Abrir AppStoreAbrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Ver fuentes de datos
Mercados
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideas de inversión
  • Empresas infravaloradas
  • Potentes generadores de dividendos
  • Compras con información privilegiada
  • Energía nuclear
  • Vehículos autónomos
  • Inteligencia artificial
  • Criptomonedas y blockchain
  • Ciberseguridad
  • Más ideas
Comunidades de acciones
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Herramientas y funciones
  • Seguimiento de la cartera
  • Buscador de valores y alertas
  • Narrativas y Valores de Feria
  • Calculadora de dividendos
Noticias y descubrimientos
  • Últimas noticias de stock
  • Incidencias del mercado global
  • El Foxhole
  • Ideas de inversión
  • Narrativas de la comunidad
  • Qué hay de nuevo
Simply Wall St
  • Planes y precios
  • Publicidad
  • Quiénes somos
  • Contacte con nosotros
  • Empleos
  • Centro de ayuda
  • Aprender a invertir en bolsa
  • Programa de afiliados
  • Empresas y negocios
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Términos y condiciones de uso
  • Política de privacidad
  • Términos de IA
  • Guía de servicios financieros